Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia
Prevalence of human papillomavirus and Helicobacter pylori in esophageal and gastroesophageal junction cancer biopsies from a case-control study in Ethiopia
Van Loon K, Mwachiro MM, Abnet CC, Akoko L, Assefa M, Burgert SL, Chasimpha S, Dzamalala C, Fleischer DE, Gopal S, Iyer PG, Kaimila B, et al. The African esophageal Cancer consortium: A call to action. J Glob Oncol. 2018;4:1-9.
McCormack VA, Menya D, Munishi MO, Dzamalala C, Gasmelseed N, Leon Roux M, Assefa M, Osano O, Watts M, Mwasamwaja AO, Mmbaga BT, Murphy G, et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors. Int J Cancer. 2017;140(2):259-71.
Leon ME, Assefa M, Kassa E, Bane A, Gemechu T, Tilahun Y, Endalafer N, Ferro G, Straif K, Ward E, Aseffa A, Schuz J, et al. Qat use and esophageal cancer in Ethiopia: A pilot case-control study. PLoS One. 2017;12(6):e0178911.
International Agency for Research on Cancer. A Review of Human Carcinogens. Volume 100, Part B: Biological Agents. Lyon: IARR; 2012.
Gheit T. Mucosal and cutaneous human papillomavirus infections and Cancer biology. Front Oncol. 2019;9:355. https://doi.org/10.3389/fonc.2019.00355.
International Agency for Research on Cancer. A Review of Human Carcinogens. Volume 61, Schistosomes, Liver Flukes and Helicobacter Pylori. Lyon: IARC; 1994.
Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to helicobacter pylori. Int J Cancer. 2015;136(2):487-90. https://doi.org/10.1002/ijc.28999.
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330(18):1267-71.
Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55(10):2111-5.
Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative helicobacter pylori infection. Gut. 1997;40(3):297-301.
Matos JI, de Sousa HA, Marcos-Pinto R, Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: A meta-analysis. Eur J Gastroenterol Hepatol. 2013;25(12):1431-41. https://doi.org/10.1097/MEG.0b013e328364b53e.
Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. Transgenic expression of helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105(3):1003-8. https://doi.org/10.1073/pnas.0711183105.
Pormohammad A, Ghotaslou R, Leylabadlo HE, Nasiri MJ, Dabiri H, Hashemi A. Risk of gastric cancer in association with helicobacter pylori different virulence factors: A systematic review and meta-analysis. Microb Pathog. 2018;118:214-9. https://doi.org/10.1016/j.micpath.2018.03.004.
Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125(6):1636-44.
Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med. 2000;191(4):587-92.
Lamb A, Yang XD, Tsang YH, Li JD, Higashi H, Hatakeyama M, Peek RM, Blanke SR, Chen LF. Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 2009;10(11):1242-9. https://doi.org/10.1038/embor.2009.210 Epub 2009 Oct 9.
Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 2008;27(2):179-92. https://doi.org/10.1007/s10555-008-9126-y.
Nesić D, Miller MC, Quinkert ZT, Stein M, Chait BT, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol. 2010;17(1):130-2. https://doi.org/10.1038/nsmb.1705.
Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447(7142):330-3.
Li N, Tang B, Jia YP, Zhu P, Zhuang Y, Fang Y, Li Q, Wang K, Zhang WJ, Guo G, Wang TJ, Feng YJ, Qiao B, Mao XH, Zou QM. Helicobacter pylori CagA protein negatively regulates autophagy and promotes inflammatory response via c-met-PI3K/Akt-mTOR signaling pathway. Front Cell Infect Microbiol. 2017;7:417. https://doi.org/10.3389/fcimb.2017.00417.
Yong X, Tang B, Li BS, Xie R, Hu CJ, Luo G, Qin Y, Dong H, Yang SM. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal. 2015;13:30. https://doi.org/10.1186/s12964-015-0111-0.
Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, et al. International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann Oncol. 2017;28(9):2086-93.
Wu DC, Wu IC, Lee JM, Hsu HK, Kao EL, Chou SH, Wu MT. Helicobacter pylori infection: A protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol. 2005;100(3):588-93.
Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O. Helicobacter pylori infection and gastric atrophy: Risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96(5):388-96.
Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, Shao L, Zou DH, Yu XM, Mao WM. Helicobacter pylori infection and esophageal cancer risk: An updated meta-analysis. World J Gastroenterol. 2013;19(36):6098-107.
Vohlonen IJ, Hakama M, Harkonen M, Malila N, Pukkala E, Koistinen V, Sipponen P. Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without helicobacter pylori infection in Finland. Gut. 2018;67(6):1201-2.
Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol. 2010;48(1):143-9.
Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol. 2006;44(2):504-12.
Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol. 2006;44(6):2025-31.
Gessner AL, Borkowetz A, Baier M, Gohlert A, Wilhelm TJ, Thumbs A, Borgstein E, Jansen L, Beer K, Mothes H, Durst M. Detection of HPV16 in esophageal Cancer in a high-incidence region of Malawi. Int J Mol Sci. 2018;12:19(2).
Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, Patel N, Mlombe YB, Mulima G, Liomba NG, Wolf LL, Shores CG, et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight. 2016;1(16):e88755.
Patel K, Mining S, Wakhisi J, Gheit T, Tommasino M, Martel-Planche G, Hainaut P, Abedi-Ardekani B. TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in Kenya. BMC Res Notes. 2011;4:469.
Antonsson A, Knight L, Whiteman DC. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens. Cancer Epidemiol. 2016;41:96-8.
Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96(6):449-55.
Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH. HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol. 2004;12(2):45-56.
Combes JD, Clavel C, Dalstein V, Gheit T, Clifford GM, Tommasino M, Franceschi S, Lacau St GJ. Human papillomavirus detection in gargles, tonsil brushings, and frozen tissues in cancer-free patients. Oral Oncol. 2018;82:34-6.
Abate E, Aseffa A, El-Tayeb M, El-Hassan I, Yamuah L, Mihret W, Bekele L, Ashenafi S, El-Dawi N, Belayneh M, El-Hassan A, Engers H. Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan. J Med Virol. 2013;85(2):282-7.
Mihret W, Yusuf L, Abebe M, Yamuah LK, Bekele L, Abate E, Wassie L, Engers H, Aseffa A. A pilot study on detection and genotyping of humanpapilloma virus isolated from clinically diagnosed Ethiopian women having cervical intraepithelial neoplasia. Ethiop Med J. 2014;(Suppl 1):49-52.
Waktola EA, Mihret W, Bekele L. HPV and burden of cervical cancer in East Africa. Gynecol Oncol. 2005;99(3 Suppl 1):S201-2.
Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703.
Taddesse G, Habteselassie A, Desta K, Esayas S, Bane A. Association of dyspepsia symptoms and helicobacter pylori infections in private higher clinic, Addis Ababa. Ethiopia Ethiop Med J. 2011;49(2):109-16.
Tedla Z. Helicobacter pylori infection in patients with upper gastrointestinal symptoms in Arba Minch hospital: Southwestern Ethiopia. Ethiop Med J. 1992;30(1):43-9.
Kibru D, Gelaw B, Alemu A, Addis Z. Helicobacter pylori infection and its association with anemia among adult dyspeptic patients attending Butajira hospital. Ethiopia BMC Infect Dis. 2014;14:656.
Kgomo M, Elnagar AA, Mokoena T, Jeske C, Nagel GJ. Prevalence of helicobacter pylori infection in patients with squamous cell carcinoma of the Oesophagus. A descriptive case series study. J Gastrointest Cancer. 2016;47(4):396-8.
Tohidpour A. CagA-mediated pathogenesis of helicobacter pylori. Microb Pathog. 2016;93:44-55.
Hatakeyama M. Structure and function of helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(4):196-219.
